清营汤对肝硬化患者血清生长激素及肝纤维化指标的影响研究

发布时间：2018-11-27 12:40

【摘要】：目的探究清营汤对感染乙肝病毒导致肝硬化的患者体内血清生长激素及肝纤维化指标变化的影响。方法选择2012年5月-2016年5月医院治疗的104例乙肝病毒感染后肝硬化患者为研究对象,按照随机数表法将患者分为试验组和对照组,每组52例,对照组患者进行注射异甘草酸镁注射液等保肝治疗,试验组患者在对照组的基础上给予患者清营汤治疗,比较两组患者治疗前后的血清生长激素(GH)和纤维化指标:透明质酸(HA)、层粘连蛋白(LN)、Ⅲ型前胶原(PC-Ⅲ)、Ⅳ型胶原(Ⅳ-C),比较两组患者治疗前后肝储备功能ChildPugh评分。结果治疗后对照组患者血清生长激素为(4.51±4.12)ug/L,透明质酸为(141.5±24.7)ug/L,层粘连蛋白(173.6±24.8)ug/L,Ⅲ型前胶原为(119.2±15.4)ug/L,Ⅳ型胶原为(104.4±12.6)ug/L,试验组患者血清生长激素为(2.98±3.28)ug/L,透明质酸为(107.2±14.7)ug/L,层粘连蛋白(139.5±17.1)ug/L,Ⅲ型前胶原为(82.2±10.9)ug/L,Ⅳ型胶原为(67.3±9.1)ug/L,两组比较差异有统计学意义(P0.05);治疗后对照组患者肝脏储备功能(Child-Pugh)评分为(6.8±1.1)分,试验组为(5.9±0.8)分,两组比较差异有统计学意义(P0.05)。结论清营汤能够有效降低乙肝病毒感染导致的肝硬化患者体内的血清生长激素和纤维化指标水平,有效治疗肝硬化患者。
[Abstract]:Objective to investigate the effect of Qingying decoction on serum growth hormone and liver fibrosis index in patients with liver cirrhosis caused by hepatitis B virus. Methods 104 patients with hepatitis B virus posthepatitic cirrhosis treated in hospital from May 2012 to May 2016 were randomly divided into two groups: experimental group (n = 52) and control group (n = 52). The patients in the control group were treated with injection of magnesium isoglycyrrhizinate and other liver protection therapy, while the patients in the experimental group were treated with Qingying decoction on the basis of the control group. Serum growth hormone (GH) and fibrosis indexes before and after treatment were compared between the two groups: (HA), hyaluronic acid (HA), laminin (LN), type 鈪，

本文编号：2360811